SOURCE: NeoStem, Inc.

November 16, 2007 11:07 ET

First Adult Stem Cell Collection to Mark Medical History in Nevada as NeoStem's Newest Collection Center Member Opens Doors on Wednesday, November 28

LAS VEGAS, NV--(Marketwire - November 16, 2007) - NeoStem, Inc. (AMEX: NBS), a leading-edge biotechnology company capitalizing on breakthroughs in the burgeoning field of adult stem cell therapeutics, has expanded its collection center network to Henderson, NV. The first official collection of adult stem cells in Nevada using NeoStem's process will occur during the Grand Opening on Wednesday, November 28. The stem cells will be cryopreserved for the individual's personal future use in times of medical need. NeoStem is the first company to provide adult stem cell collection and banking services to the general population. The concept is basic, and the procedure is simple. Like donating blood, adult stem cells are extracted from a blood draw, clinically separated, and prepared for long-term storage preservation utilizing NeoStem's proprietary processes and technologies. Individuals may use their stored stem cells for therapeutic transplant in any licensed transplant center in the US for approved therapies. "It is a relatively simple, yet powerful way to protect long-term health," said Robin Smith, M.D., Chairman and Chief Executive Officer of NeoStem.

"My own stem cells saved my life," remarks Michael Carlat, an adult stem cell cardiac transplant survivor and Nevada resident. "We are fortunate to have access to this life-saving technology available to us right here in Las Vegas."

Today, adult stem cells are the standard of care in treating bone marrow cancers, such as leukemia, lymphomas, and multiple myelomas. Other diseases such as radiation sickness have successfully been treated as well. Currently, more than 750 clinical trials in the US are using stem cells for breakthrough therapies for serious diseases such as cancer, diabetes, heart and vascular disease and autoimmune disorders.

"Individuals with a family history of life-threatening diseases, who collect and store their own adult stem cells, will be among the first to benefit from the life-saving progress resulting from current clinical trials and research," emphasizes Dr. Ivan Goldsmith, the Nevada facility medical director. "As the nation's population ages and encounters health issues, NeoStem's services provide personal 'bio-insurance' to help ensure a healthy future."

The open house will be held Wednesday, November 28, 2007. The Ribbon Cutting and first adult stem cell collection procedure will be held at 10:30 a.m. The Open House will run from 11 a.m. until 4 p.m. A Special Reception with cocktails and hors d'oeuvres will be held from 5 p.m. to 8 p.m.

The new Collection Center is located in the TrimCare Medical Center, 10652 S. Eastern Ave., Suite A, Henderson, Nevada. Please RSVP to 702.990.0899 or LPhelps@solutionsinmarketing.net.

About NeoStem, Inc.

NeoStem is a biotechnology company enhancing the delivery of adult stem cell therapeutics to health-conscious consumers. The Company is developing a nationwide network of adult stem cell collection centers, enabling people to donate and store their own stem cells with NeoStem for personal use years or decades later in times of critical medical need. Although adult stem cell therapies are generally not standard of care, the Company believes medicine is on the threshold of a plethora of such new therapies.

The proprietary NeoStem technologies empower health-conscious consumers to help protect their future health by undergoing treatment with their own stem cells -- providing an accessible supply of healthy, genetically matched stem cells for use in the eventuality of illness. Currently underway are hundreds of stem cell-based research programs and clinical trials investigating the use of these non-controversial adult stem cells, such as those collected from donors under NeoStem's methods. As the nation's population ages and encounters serious age-related and congenital health issues, NeoStem has positioned itself as a leader in the national trend toward protecting one's future health.

The Company's business plan involves opening a nationwide network of adult stem cell collection facilities. Its stem cell collection systems will be located in physician offices and medical facilities, where the procedures and care can be administered by trusted personal doctors and medical professionals. For more information, please visit: www.neostem.com.

Certain statements in this press release constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, including statements concerning the ability of NeoStem, Inc. ("the Company") to develop the adult stem cell business, the future of regenerative medicine and the role of adult stem cells in that future, the future use of adult stem cells as a treatment option and the potential revenue growth of the Company's business. Such forward-looking statements involve known and unknown risks, uncertainties and other factors, which may cause the actual results, performance or achievements of the Company, or industry results, to be materially different from any future results, performance, or achievements expressed or implied by such forward-looking statements. The Company's ability to enter the adult stem cell arena, its success in such arena and future operating results are dependent upon many factors, including but not limited to (i) the Company's ability to obtain sufficient capital or a strategic business arrangement to fund its expansion plans; (ii) the Company's ability to build the management and human resources and infrastructure necessary to support the growth of its business; (iii) competitive factors and developments beyond the Company's control; (iv) scientific and medical developments beyond the Company's control; (v) the Company's inability to obtain appropriate state licenses or any other adverse effect or limitations caused by government regulation of the business; (vi) whether any of the Company's current or future patent applications result in issued patents; and (vii) other risk factors discussed in the Company's periodic filings with the Securities and Exchange Commission which are available for review at www.sec.gov under "Search for Company Filings."

NeoStem, Inc.
420 Lexington Avenue, Suite 450
New York, NY 10170
Phone (212) 584-4180

Contact Information